UBC Medical Indonesia Tbk. vs Trimitra Propertindo Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Trimitra Propertindo Tbk. trades at Rp77 (market cap 226.2B, 76.19M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.5× Trimitra Propertindo Tbk.'s market cap, and Trimitra Propertindo Tbk. is more actively traded (76.19M versus 3.48M). Which is the better fit depends on your goals.
| LABS | LAND | |
|---|---|---|
Market Cap | 576.7B | 226.2B |
Volume | 3.48M | 76.19M |
Lot | 34.82K | 761.87K |
Turnover | 522.79M | 5.92B |
Average Price | 150.13 | 77.67 |
Value | 522.79M | 5.92B |
Indicative Equilibrium Price | 148 | 77 |
Indicative Equilibrium Volume | 350 | 21.69K |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Trimitra Propertindo Tbk (The Entity) was established based on Notarial Deed of Udin Narsudin, S.H., MKn., No. 46 dated December 13, 2012.
Read more on LAND →